Simplifying HCV Assessment and Treatment
  • CME
  • CE

This video capture of a plenary presentation from the 2019 CCO Hepatitis Annual Meeting reviews evidence-based approaches to streamlining the pretreatment workup, treatment selection process, on-treatment monitoring, and post-treatment management of HCV infection.
Ira M. Jacobson, MD
Program Director
Jordan J. Feld, MD, MPH
Physicians: maximum of 0.75 AMA PRA Category 1 Credits
Registered Nurses: 0.7 Nursing contact hours
Pharmacists: 0.75 contact hours (0.075 CEUs)
Released: August 23, 2019 Expiration: August 22, 2020

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Implement practical strategies to simplify pretreatment assessment when caring for patients with HCV infection
  • Integrate the results of clinical studies of approved HCV treatments into optimized patient management strategies
  • Apply key guidelines and study data to ensure appropriate, individualized on-treatment management and post-treatment follow-up when providing HCV therapy

Information on this Educational Activity

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Program Director

Ira M. Jacobson, MD

Director of Hepatology
Department of Medicine
NYU School of Medicine
New York, New York

Ira M. Jacobson, MD, has disclosed that he has received consulting fees from AbbVie, Arrowhead, Assembly Biosciences, Bristol-Myers Squibb, Gilead Sciences, Intercept, Janssen, Merck, Novo Nordisk, Siemens, and Springbank and funds for research support from Assembly Biosciences, Bristol-Myers Squibb, Enanta, GENFIT, Gilead Sciences, and Janssen.

Faculty

Jordan J. Feld, MD, MPH

Associate Professor of Medicine
University of Toronto
Hepatologist
Toronto Centre for Liver Disease
Sandra Rotman Centre for Global Health
Toronto, Canada

Jordan J. Feld, MD, MPH, has disclosed that he has received consulting fees from Contravir, Enanta, and Roche and funds for research support from AbbVie, Gilead Sciences, and Janssen.

Staff

Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer Blanchette, PhD, has no relevant conflicts of interest to report.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no relevant conflicts of interest to report.
Edward King, MA

Executive Vice President

Edward King, MA, has no relevant conflicts of interest to report.
Alice I. Sato, MD, PhD
Alice I. Sato, MD, PhD, has no relevant conflicts of interest to report.

Target Audience

This program is intended for hepatologists, gastroenterologists, infectious diseases clinicians, registered nurses, pharmacists, and other healthcare professionals involved in the care of patients with viral hepatitis.

Goal

The goal of this activity is to improve participants’ competence in addressing the most important and most current challenges in viral hepatitis management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic.

Physician Continuing Medical Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

0.7 contact hours may be earned for successful completion of this activity.

Pharmacist Continuing Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

This program is assigned ACPE Universal Activity 0797-9999-19-091-H01-P . This program is designated for up to 0.75 contact hours (0.075 CEUs) of continuing pharmacy education credit.

Type of Activity Knowledge

For Pharmacists: Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 23, 2019, through August 22, 2020:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Expert commentary on the importance of improving HCV treatment uptake in persons who inject drugs and effective linkage-to-care strategies

Oluwaseun Falade-Nwulia, MBBS, MPH Released: October 14, 2019

Clinical Care Options’ expert audio from Matthew J. Akiyama, MD, MSc, on challenges and opportunities for reducing HCV in correctional facilities

Matthew J. Akiyama, MD, MSc Released: October 10, 2019

Downloadable slides from Clinical Care Options providing expert insights on HCV identification and care in correctional settings

Matthew J. Akiyama, MD, MSc Released: October 8, 2019

Audio from Dr. Ira Jacobson on evidence for treating patients with immune-tolerant CHB and whether ALT 2 or more x ULN should define HBV treatment candidacy

Ira M. Jacobson, MD Released: September 5, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?